Cite
HARVARD Citation
Honda, K. et al. (2018). Usefulness of semiquantitative PCR‐Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b. Hepatology research. 48 (4), pp. 255-263. [Online].